FFCP PHASE1:Mm9::chr11:43412215..43412219,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=131|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:43412215..43412219,-|id=chr11:43412215..43412219,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000331!1.56e-38!3;UBERON:0002116!1.56e-38!3;UBERON:0001204!1.56e-38!3;UBERON:0001168!1.56e-38!3;UBERON:0001962!3.19e-25!2;UBERON:0001961!3.19e-25!2;UBERON:0001744!3.19e-25!2;UBERON:0000344!4.29e-21!15;UBERON:0002465!3.41e-17!3;UBERON:0003199!1.55e-13!1;UBERON:0004923!2.46e-13!24;UBERON:0001242!1.70e-09!13;UBERON:0000060!1.70e-09!13;UBERON:0001262!1.70e-09!13;UBERON:0004786!1.70e-09!13;UBERON:0007023!5.12e-09!51;UBERON:0002108!7.77e-08!16;UBERON:0000160!1.22e-07!43;UBERON:0001155!1.76e-07!2;UBERON:0000059!1.76e-07!2|ontology_enrichment_uberon_v019_2=UBERON:0000331,3.28e-58,3;UBERON:0002116,3.28e-58,3;UBERON:0001204,3.28e-58,3;UBERON:0001168,3.28e-58,3;UBERON:0002108,4.54e-44,4;UBERON:0001242,1.42e-14,13;UBERON:0001262,1.42e-14,13;UBERON:0004786,1.42e-14,13;UBERON:0000344,8.25e-13,15;UBERON:0004923,1.75e-08,24;UBERON:0000160,7.72e-07,31|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159992422793407,0.22940928106717,0,0,0,5.89072600314759,0.504060259519861,1.33038306393183,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255457055208591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.898819408654221,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr11:43412215..43412219,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=131 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:43412215..43412219,- | |||
|description=CAGE_peak_at_chr11:43412215..43412219,- | |||
|id=chr11:43412215..43412219,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000331!1.56e-38!3;UBERON:0002116!1.56e-38!3;UBERON:0001204!1.56e-38!3;UBERON:0001168!1.56e-38!3;UBERON:0001962!3.19e-25!2;UBERON:0001961!3.19e-25!2;UBERON:0001744!3.19e-25!2;UBERON:0000344!4.29e-21!15;UBERON:0002465!3.41e-17!3;UBERON:0003199!1.55e-13!1;UBERON:0004923!2.46e-13!24;UBERON:0001242!1.70e-09!13;UBERON:0000060!1.70e-09!13;UBERON:0001262!1.70e-09!13;UBERON:0004786!1.70e-09!13;UBERON:0007023!5.12e-09!51;UBERON:0002108!7.77e-08!16;UBERON:0000160!1.22e-07!43;UBERON:0001155!1.76e-07!2;UBERON:0000059!1.76e-07!2 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000331,3.28e-58,3;UBERON:0002116,3.28e-58,3;UBERON:0001204,3.28e-58,3;UBERON:0001168,3.28e-58,3;UBERON:0002108,4.54e-44,4;UBERON:0001242,1.42e-14,13;UBERON:0001262,1.42e-14,13;UBERON:0004786,1.42e-14,13;UBERON:0000344,8.25e-13,15;UBERON:0004923,1.75e-08,24;UBERON:0000160,7.72e-07,31 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159992422793407,0.22940928106717,0,0,0,5.89072600314759,0.504060259519861,1.33038306393183,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255457055208591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.898819408654221,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:43412215..43412219,- | |||
}} |
Latest revision as of 22:13, 5 August 2015
Short description: | p@chr11:43412215..43412219, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:43412215..43412219, - |
Coexpression cluster: | MCL_coexpression_mm9:131 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
ileal mucosa | 3.28e-58 | 3 |
ileum | 3.28e-58 | 3 |
mucosa of small intestine | 3.28e-58 | 3 |
wall of small intestine | 3.28e-58 | 3 |
small intestine | 4.54e-44 | 4 |
intestinal mucosa | 1.42e-14 | 13 |
wall of intestine | 1.42e-14 | 13 |
gastrointestinal system mucosa | 1.42e-14 | 13 |
mucosa | 8.25e-13 | 15 |
organ component layer | 1.75e-08 | 24 |
intestine | 7.72e-07 | 31 |